Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation
- PMID: 422225
- PMCID: PMC1457394
Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation
Abstract
The effects of propamidine and their dose dependency, on utilization of the third and fifth complement components in immune haemolysis have been compared. While C3 utilization is not disturbed that of C5 is markedly inhibited by propamidine in concentrations as low as 0.5 mM. Both, binding of C5 to surface-fixed C3b and cleavage of C5 by convertases C42 and C3bBb, are also inhibited in the presence of propamidine. Since neither C3 cleavage by these enzymes nor even C5 cleavage by the cobra venom factor-supported convertase CFVBb is significantly reduced a general convertase-inhibiting effect of propamidine is ruled out. Rather the effect on utilization of C5 is the result of interference with binding of C5 is the result of interference with binding of C5 to C3b and hence impairment of its accessibility to the convertases. These findings thus further support the role of surface fixed C3b in C5 activation proposed earlier.
Similar articles
-
Multiple effects of a diamidine (propamidine) on complement activation.Immunology. 1979 Jan;36(1):131-7. Immunology. 1979. PMID: 422224 Free PMC article.
-
Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.J Immunol. 1996 Jul 15;157(2):884-91. J Immunol. 1996. PMID: 8752942
-
C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.J Immunol. 1988 Dec 1;141(11):3895-901. J Immunol. 1988. PMID: 3183384
-
Factors and conditions essential for activation of the fifth component of complement and release of anaphylatoxin (C5a).Monogr Allergy. 1977;12:86-9. Monogr Allergy. 1977. PMID: 335222 Review. No abstract available.
-
Structure/function of C5 convertases of complement.Int Immunopharmacol. 2001 Mar;1(3):415-22. doi: 10.1016/s1567-5769(00)00039-4. Int Immunopharmacol. 2001. PMID: 11367526 Review.
Cited by
-
Multiple effects of a diamidine (propamidine) on complement activation.Immunology. 1979 Jan;36(1):131-7. Immunology. 1979. PMID: 422224 Free PMC article.
-
Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.Clin Exp Immunol. 1983 Sep;53(3):555-61. Clin Exp Immunol. 1983. PMID: 6616956 Free PMC article.
-
The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.Biochem J. 1981 Dec 1;199(3):485-96. doi: 10.1042/bj1990485. Biochem J. 1981. PMID: 6462133 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous